Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew P. Frosch, M.D.,Ph.D.


This page shows the publications co-authored by Matthew Frosch and Teresa Gomez-Isla.
Connection Strength

  1. The Challenge of Defining Alzheimer Disease Based on Biomarkers in the Absence of Symptoms. JAMA Neurol. 2019 Jul 15.
    View in: PubMed
    Score: 0.825
  2. Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3ß) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation. iScience. 2021 Feb 19; 24(2):102058.
    View in: PubMed
    Score: 0.229
  3. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019 03 11; 7(1):37.
    View in: PubMed
    Score: 0.201
  4. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology. Neurobiol Dis. 2019 01; 121:327-337.
    View in: PubMed
    Score: 0.196
  5. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Neurology. 2019 07 30; 93(5):e476-e484.
    View in: PubMed
    Score: 0.051
  6. Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue. Sci Rep. 2016 09 15; 6:33079.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.